Abstract
A recognition and understanding of the factors that make a patient truly at high risk for unsupported coronary angioplasty (PTCA) are necessary for the proper implementation of supported PTCA or an avoidance of the technique of PTCA altogether.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Holmes DR Jr., Holubkov R, Vlietstra RE, et al. Co-investigators of the National Heart, Lung, and Blood Institute Percutaneous Transluminal Coronary Angioplasty Registry. Comparison of complications during percutaneous transluminal coronary angioplasty from 1977 to 1981 and from 1985 to 1986: The National Heart, Lung and Blood Institute Percutaneous Transluminal Coronary Angioplasty Registry.J Am Call Cordial1988; 12:1149–1155.
de Feyter PJ, Serruys PW, Wijns W, van den Brand M. Emergency PTCA in unstable angina pectoris refractory to optimal medical treatment.N Engl J Med1985; 313:342–346.
de Feyter PJ, Serruys PW, Soward A, van den Brand M, Bos E, Hugenholtz PG. Coronary angioplasty for early postinfarction unstable angina.Circulation1985; 74:1365–1370.
de Feyter PJ, Suryapranata H, Serruys PW, et al. Coronary angioplasty for unstable angina: Immediate and late results in 200 consecutive patients with identification of risk factors for unfavorable early and late outcome. J AmColl Cardiol1988; 12:324–333.
Gottlieb SO, Walford GD, Ouyang P, et a]. Initial and late results of coronary angioplasty for early postinfarction unstable angina.Cathet Cordial/as(ping1987; 13:93–99.
Saban RD, Snyder LD, Synder BA, McKay RG, Lorell BH, Aroesty JM, Pasternak RC, Bradley AB, Monrad ES, Bains DS. Usefulness of percutaneous transluminal coronary angioplasty for unstable angina pectoris after non-Q-wave acute myocardial infarction.Am J Cordial1987; 59263–266.
Black Al, Brown CS, Feres F, Roubin GS, Douglas JS. Coronary angioplasty and the spectrum of unstable angina pectoris: What determines risk? (abstr).Circulation1988; 78(Suppl. II):11–8.
Kamp O, Beatt KJ, de Feyter PJ, et al. Short-, medium-, and long-term follow-up after percutaneous transluminal coronary angioplasty for stable and unstable angina pectoris.Am Heart J1989; 117:991–996.
Goldbaum T, Diciascio G, Cowley MJ, Vetrovec GW. Early occlusion following successful coronary angioplasty: Clinical and angiographie observations.Cathete Cardiovasc Diag1989; 17:22–27.
Simpfendorfer C, Raymond R, Schraider J, et al. Early and long-term results of percutaneous transluminal coronary angioplasty in patients 70 years of age and older with angina pectoris.Am J Cardin!1988; 61:457--458.
Kern MJ, Deligonul U, Galan K, et al. Percutaneous transluminal coronary angioplasty in octogenarians.Am J Cardiol1988; 61:457–458.
Good TH, Calkins M, Ligon R, McCallister BD, Hartzler GO. PTCA in the ultra-elderly (abstr).Circulation1987; 76(Suppl. IV):IV-464.
Kelsey SF, Miller DP, Leatherman LL, Cowley MJ, NHLBI PTCA Registry Investigators. Coronary angioplasty in the elderly: 1985–1986 NHLBI PTCA Registry.Circulation1988; 78(Suppl. B):11–283.
Lewin RF, Dorros G, Mathiak ML. Long term followup after successful coronary angioplasty in patients of age ?70 years (abstr).J Am Coll Cardiol1988; 11:51.
Coca F, Fajadet J, Caster L, Marco J. Transluminal coronary angioplasty in the elderly (over 70 years old): Immediate and long term results (abstr).Eur Heart J1987; 8(Suppl. 11):220.
Imburgia M, King TR, Soffer AD, Rich MW, Krone RJ, Salimi A. Early results and longterm outcome of percutaneous transluminal coronary angioplasty in patients age 75 years or older.Am J Cardiol1989; 1127–1129.
Ellis SG, Roubin GS, King SB, et al. Angiographie and clinical predictors of acute closure after native vessel coronary angioplasty.Circulation1988; 77:372–379.
McEniery PT, Hollman J, Knezinek V, et al. Comparative safety and efficacy of percutaneous transluminal coronary angioplasty in men and in women.Cathet Cardiovasc Diag1987; 13:364–371.
Kelsey SF, Cowley MJ, Costigan T, Detre KM, Passamani E, Robertson T. Results of PTCA in women in 1985 (abstr).JAmColl Curdle!1987; 9:56.
Lorell BH, McCabe CH, Sipperly ME, Bairn DS. Women and PICA: No feminine mystique.Circulation1987; 76(Suppl. IV):IV-400.
Pocock SJ, Hughes MD, Lee RJ. Statistical problems in the reporting of clinical trials.N Eng! J Med1987; 317:426–432.
Ellis S, Cowley M, Vandormael M, Bulle T, DiSciascio G, and the MAPS Group. Risk of angioplasty in multivessel disease - improved assessment with modified ACCIAHA score. Circulation, submitted, 1990.
Conti CR, Brawley RK, Griffith LSC, et al. Unstable angina pectoris: Morbidity and mortality in 57 consecutive patients evaluated angiographically.Am J Cardio!1973; 32:745–750.
Cairns JA, Fantus JG, Klassen GA. Unstable angina pectoris.Ant HeartJ1976; 92:373–386.
Scanlon PJ. The intermediate coronary syndrome.Prag Cardiovasc Dis1981; 23:351–364.
Theroux P, Ouimet H, McCans J, et al. Aspirin, heparin, or both to treat acute unstable angina.N Eng! J Med1988; 319:1105–1111.
Sherman CD, Litvack F, Grundfest W, et al. Coronary angioscopy in patients with unstable angina pectoris.N Eng! J Med1986; 315:913–919.
Douglas JS, Lutz JF, Clements SD, et al. Therapy of large intracoronary thrombi in candidates for percutaneous translurninal coronary angioplasty (abstr).J Am Coll Cardiol1988; 11:238.
Vetrovec GW, Leinbach RC, Gold HR, et al. Intracoronary thrombolysis in syndromes of ischemia: Angiographie and clinical results.Am Heart J1984; 104:946–952.
Gotoh K, Minamino T, Katoh O, et al. The role of intracoronary thrombus in unstable angina: Angiographic assessment and thrombolytic therapy during ongoing attacks.Circulation1988; 77:526–534.
Gold HK, Johns JA, Leinbach RC, et al. A randomized, blinded, placebo-controlled trial of recombinant human tissue-type plasminogen activator in patients with unstable angina pectoris.Circulation1987; 75:1192–1199.
Topol EJ, Nicklas JM, Kander N, et al. Need for definitive coronary revascularization despite intravenous tissue plasminogen activator (t-PA) for unstable angina: Results of a randomized, double-blind, placebo-controlled trial.Circulation1987; 76(Suppl. IV):IV-452
Bates ER, McGillem MJ, Mickelson JK, Pitt B, Mancini G131. A monoclonal antibody to the platelet receptor GPI-lb/11A (7E3) preventsacutethrombosis in a canine model of coronary angioplasty.Circulation1988; 78:11–289.
Coller BS, Folts JD, Scudder LE, Smith SR. Antithrombotic effect of a monoclonal antibody to the platelet glycoprotein Ilb/lila receptor in an experimental animal model.Blood1986; 68:783–786.
Cowley MJ, Corros G, Kelsey SF, Van Raden M, Detre KM. Acute coronary events associated with percutaneous transluminal coronary angioplasty.AtnJ Cardio! 1983;53:12C–16C.
Ryan TJ, Faxon DP, Gunnar RM, et al. Guidelines for percutaneous transluminal coronary angioplasty: A report of the American College of Cardiology/American Heart Association Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures (Subcommittee on Percutaneous Transluminal Coronary Angioplasty). JAm Coll Cardio!1988; 12:529–545.
Yock PG, Linker DT. Catheter-based two-dimensional ultrasound imaging. In Topol EJ, edTextbook of Interventional Cardiology.W.S. Saunders, Philadelphia, 1990, p. 816.
Topol EJ, Ellis SG, Fishman J, et al. Multicenter study of percutaneous transluminal angioplasty for right coronary artery ostial stenosis.J Am Coll Cardiol1987; 9:1214–1218.
Cote G, Myler RK, Stertzer SH, et al. Percutaneous transluminal angioplasty of stcnotic coronary artery bypass grafts: 5 years’ experience. J AmColl Cardio!1987; 9:8–17.
Douglas JS Jr., Gruentzig AR, King SB, et al. Percutaneous transluminal coronary angioplasty in patients with prior coronary bypass surgery. JAm Coll Cardiol1983; 2:745–754.
Saber RS, Edwards WD, Holmes DR Jr., Vlietstra RE, Reeder GS. Balloon angioplasty of aortocoronary saphenous vein bypass grafts: A histopathologic study of six grafts from five patients, with emphasis on restenosis and embolic complications.JAmColl Cardiol1988; 12:1501–1509.
Corbelli J, Franco I, Hollman J, Simpfendorfer C, Galan K. Percutaneous transluminal coronary angioplasty after previous coronary artery bypass surgery.Am J Cardio!1985; 56:398–403.
Kussmaul JG. Percutaneous angioplasty of coronary bypass grafts: An emerging consensus.Cathet Cardiorasc Diag1988; 15:1–4.
Liu MW, Douglas JS, King SB, Gruentzig A. Angiographie predictors of coronary embolization in the PTCA of vein graft lesions (abstr).Circulation1989; 80(Suppl. II):11–172.
Aueron F, Gruentzig A. Distal embolization of a coronary artery bypass graft atheroma during percutaneous transluminal coronary angioplasty.Ain J Cardiol1984; 53:953–954.
Shintshak TM, Giorgi LV, Johnson WL, et al. Application of percutaneous transluminal coronary angioplasty to the internal mammary artery graft. J Ant Col!Cardio!1988; 12:1205–1214.
Hill DM, McAuley BJ, Sheehan DJ, et al, Percutaneous transluminal angioplasty of internal mammary artery bypass grafts.J Am Coll Cardiol1989; 13:221A.
Bell MR, Vlietstra RE, Bresnahan DR, Holmes DR. Percutaneous transluminal angioplasty of left internal mammary artery grafts using a femoral approach. JAm Coll Cardiol1989; 13:221A.
Sketch MH, Perez JA, Quigley PJ, et al. Internal mammary artery graft angioplasty; Clinical and angiographie follow-up.J Am Coll Cardio!1989; 13,221A.
Andreae GE, Myler RK, Clark DA, Shaw RE, Murphy MC. Acute complications following angioplasty of totally occluded vessels.Circulation1987; 76(Suppl. IV):IV-400.
Klein LW, Agarwal JB, Helfant RH. The resolution of coronary collaterals after successful percutaneous transluminal coronary angioplasty.Am Heart1988; 115:554–558
O’Keefe JH, Reeder GS, Miller GA, Bailey KR, Holmes DR. Safety and efficacy of percutaneous transluminal coronary angioplasty performed at time of diagnostic catheterization compared with that performed at other times.Am J Cardio!1989; 63:27–29.
Schwartz L, Bourassa MG, Lesperance J, et al. Aspirin and dipyridamole in the prevention of restenosis after percutaneous transluminal coronary angioplasty.N Eng! J Med1988; 318:1714–1719.
White CW, Chaitman B, Lassar TA, et al., and the Ticlopidine Study Group (abstr).Circulation1987; 76(Suppl. IV):IV-400.
Chesebro JH, Webster MWI, Reeder GS, Mock MB, Grill DE, Bailey KR, Steichen S, Fuster V. Coronary angioplasty: Antiplatelet therapy reduces acute complications but not restenosis (abstr)Circulation1989; 80(Suppl. 1):II-64.
Mufson L, Black A, Roubin G, et al. A randomized trial of aspirin in PTCA: Effect of high vs. low dose aspirin on major complications and restenosis (abstr).JAmColt Cardiol1988; 11:236.
Lembo NJ, Black AJ, Roubin GS, et al. Does the addition of dipyridamole to aspirin decrease acute coronary angioplasty complications? The results of a prospective randomized clinical trial (abstr).J Am Coll Cardiol1988; 11:237.
Emory University Coronary Angiography Data Bank, unpublished observations.
Patrono C, Ciabattoni G, Patrignani P, et al. Clinical pharmacology of platelet cyclooxygenase inhibition.Circulation1985; 72:1177–1184.
Paton TW, Walker SE, Leung FYK, Little AH. Effect of cimetidinc on bioavailability of enteric coated aspirin tablets.Clin Pharm1983; 2:165–166.
Swanson KT, Vlietstra RE, Holmes DR, et al. Efficacy of adjunctive dextran during per-cutaneous transluminal coronary angioplasty.Am J Cardiol 1984;54:447–448.
Bygdeman S, Eliasson R, Guibring B. Effect of dextran infusion on the adenosine phosphate-induced adhesiveness and the spreading capacity of human blood platelets.Thrornb Diatb Hacrnorrh1966; 15:451–456.
Weiss HJ. The effect of clinical dextran on platelet aggregation, adhesion, and the ADP release in man: In vivo and in vitro studies.J Lab Clin Med1967; 69:37–46.
Data LL, Nies AS. Dextran 40.Ann Intern Med1974; 81:500–504.
Heras M, Chesebro JH, Penny WJ, et al. Importance of adequate heparin dosage in arterial angioplasty in a porcine model.Circulation1988; 78:654–660.
Saba 141, Saba SR, Morelli GA. Effect of heparin on platelet aggregation.Anil Hematol1984; 17:295–306.
Salzman EW, Rosenberg RD, Smith MH, Lindon JN, Favreau L. Effect of heparin and heparin fractions on platelet aggregation.J Clin Invest1980; 65:64–73.
Saba HI, Saba SR, Blackburn CA, Hartman RC, Mason RG. Heparin neutralization of PGI2: Effects upon platelets.Science1979; 205:499–501.
Ellis SG, Roubin GS, WilentzjDouglas JS, King SB. Effect of 18- to 24-hour heparin administration for prevention of restenosis after uncomplicated coronary angioplasty.Am Heart J 1989; 117:777–782.
Lukas MA, Deutsch E, Laskey WK. Beneficial effect of heparin therapy on PTCA outcome in unstable angina (abstr). JAm Coll Cardiol1988; (Suppl. II):132.
Gabliani G, Deligonul U, Kern MJ, Vandormael M. Acute coronary occlusion occurring after successful percutaneous transluminal coronary angioplasty: Temporal relationship to discontinuation of anticoagulation.Am Heart J1988; 116:696–700.
Ogilby JD, Kopelman HA, Klein LW, Agarwal JB. Adequate heparinization during PTCA: Assessment using activated clotting time (abstr).J Am Coll Cardiol1988; 11:237.
Hariuchi K, Mizuno K, Matsui H, et al. Improved ischemic tolerance during percutaneous transluminal coronary angioplasty (PTCA) by antianginal agents (abstr).Circulation1987; 76 (Suppl. I V):IV-275.
Darius H, Schmucker B. Antianginal agents administered intracoronarily ameliorate functional impairment and extend time to ischemia during PTCA.Circulation 1987; 76(Suppl. lV):IV-275.
Lam JYT, Chesebro JH, Fuster V. Platelets. Vasoconstriction and nitroglycerin during arterial wall injury. A new antithrombotic role for an old drug.Circulation1988; 78:712–716.
Babbit DG, Perry JM, Forman MB. Intracoronary verapamil for reversal of refractory coronary vasospasm during percutaneous transluminal coronary angioplasty.J Am Coll Cardiol1988; 12:1377–1381.
Fischell TA, Derby G, Tse TM, Stadius ML. Coronary artery vasoconstriction routinely occurs after percutaneous transluminal coronary angioplasty.Circulation1988; 78:1323–1334.
Holtman J, Gruentzig AR, Douglas JS Jr., King SB, ischinger T, Meier B. Acute occlusion after percutaneous transluminal coronary angioplasty - A new approach.Circulation1983; 68:725–732.
Sinclair IN, McCabe GH, Sipperly ME, Bairn DS. Abrupt reclosure: Predictors, therapeutic options, and long-term outcome.J Am Coil Cardiol1988; 11:132A.
Palazzo AM, Gustafson GM, Santini E, Kemp HG. Unusually long inflation times during percutaneous transluminal coronary angioplasty.Cathet Cardiovasr Dian1958; 14:154–158.
Smith JE, Quigley PJ, Tcheng JE, Bauman RP, Thomas J, Stack RS. Can prolonged perfusion balloon inflations salvage vessel patency after failed angioplasty? (abstr).Circulation1989; 80(Suppl. II):I1–373.
Hinohara T, Simpson JB, Phillips HR, et al. Transluminal catheter reperfusion: A new technique to reestablish blood flow after coronary occlusion during percutaneous trans-lumina] coronary angioplasty.Aar J Cardiol1985; 57:684–686.
Hinohara T, Simpson JB, Phillips HR, Stack RS. Transluminal intracoronary reperfusion catheter: A device to maintain coronary perfusion between failed coronary angioplasty and emergency coronary bypass surgery.J Am Coll Cordial1988; 11:977–982.
Douglas JS, King SB, Roubin GS, Murphy DA, Namay DL, Anderson HV. Efficacy of coronary artery perfusion catheters in patients with failed angioplasty and acute myocardial ischemia. JAm Coll Cardiol1987; 9:105A.
Sigwart U, Urban P, Golf S, et al. Emergency stenting for acute occlusion after coronary balloon angioplasty.Circulation 1988; 78:1121–1127.
Sinclair IN, Dear WE, Saftan RD, Plokker TM, Spears JR, the LBA Study Group. Acute closure post PICA successfully treated with laser balloon angioplasty (abstr).Circulation1989; 80(Suppl. II):II-476.
Kerciakes D. Personal communication.
Cohen BM, Buchbinder M, Kozina J, Podolia R, Peterson KL, Ross J Jr. Rethrombosis during angioplasty in myocardial infarction and unstable syndromes: Efficacy of intracoronary urokinase and redilation (abstr).Circulation1988; 78(Suppl. II):II-8.
Curling PE, Weintraub WS, Joncs EL, Talley D, Craver JM, Guyton RA. Failed elective coronary angioplasty mandating bypass surgery vs. elective coronary surgery: A case control study.Circulation 1988;78(Suppl. 1I):II-476.
Ellis SG, Roubin GS, King SB, et al. In-hospital cardiac mortality after acute closure after coronary angioplasty: Analysis of risk factors from 8207 procedures.J Am Coil Cardiol1988; 11:211–216.
Park DD, Laramec LA, Tcirstcin P, et al. Major complications during PTCA: An analysis of 5413 cases (abstr). JAnt Coll Cardiol1988; 11:237.
Harnarayan C, Bennett, MA, Pentecost BL, Brewer 11B. Quantitative study of infarcted myocardium in cardiogenic shock.Br Heart J1970; 32:728–732.
Kalbfleisch H, Hort W. Quantitative study on the size of coronary artery supplying areas postmortem.Ain Heart J1977; 94:183–188.
James TN. Anatomy of the coronary arteries in health and disease.Circulation1965; 32:1020–4029.
Kennedy JW, Kaiser G, Fisher L. Multivariate discriminant analysis of the clinical and angiographic predictors of operative mortality from the collaborative study in coronary artery surgery (CASS).J Thorax Cardiovasr Surg1980; 80:876–882.
Kennedy JW, Kaiser G, Fisher L, et al. Clinical and angiographie predictors of operative mortality from the collaborative study in coronary artery surgery (CASS).Circulation1981; 63:793–799.
Kirklin JW, Blackston E, Rogers WJ. The plights of the invasive treatment of ischemic heart disease. JAm Coil Cardiol1985; 5:158–167.
Vogel RA. Supported angioplasty. In Topol EJ, edTextbook i f Interventional Cardiology.W.B. Saunders, Philadelphia, 1990, pp. 467–476.
Smalling RW, Sweeney MJ, Cassidy DB, Barrett RL, Morris RE, Lammermeier DE, Key PG, Haynie MP, Frazier OH, Wampler R. Hemodynamics in cardiogenic shock after acute myocardial infarction with the hemopump assist device.Circulation1989; 80(Suppl. II): 11–624.
Jacobs AK, Faxon DP. Retroperfusion and PTCA. In Topol EJ, edTextbook of Interventional Cardiology.W.B. Saunders, Philadelphia, 1990, pp. 477–495.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1991 Springer Science+Business Media New York
About this chapter
Cite this chapter
Ellis, S.G. (1991). Identification of the High Risk Angioplasty Patient. In: Shawl, F.A. (eds) Supported Complex and High Risk Coronary Angioplasty. Interventional Cardiology, vol 1. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-3890-5_1
Download citation
DOI: https://doi.org/10.1007/978-1-4615-3890-5_1
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-6735-2
Online ISBN: 978-1-4615-3890-5
eBook Packages: Springer Book Archive